Ex Parte HASLWANTER et al - Page 3


                 Appeal No. 2002-0535                                                          Page 3                  
                 Application No.  09/303,413                                                                           
                        In response appellants point out (Brief, page 5), “it is not at all apparent                   
                 what function is served by zinc oxide in the Suffis et al. compositions.  This                        
                 component is present in only the ointments of Example H and does not appear                           
                 to be discussed at another point in the disclosure or to be mentioned in the                          
                 claims.”  We agree.                                                                                   
                        We find no disclosure in Suffis of zinc oxide having pigmentation or skin                      
                 protectant properties.  The examiner’s unsupported assertion is not sufficient to                     
                 support a prima facie case of obviousness.  See In re Lee, 277 F.3d 1338, 1343-                       
                 1344, 61 USPQ2d 1430, 1433-1434 (Fed. Cir. 2002).  See also W.L. Gore &                               
                 Assocs., Inc. v. Garlock, Inc., 721 F.2d 1540, 1552, 220 USPQ 303, 312-313                            
                 (Fed. Cir. 1983):  “To imbue one of ordinary skill in the art with knowledge of the                   
                 invention.., when no prior art reference or references of record convey or                            
                 suggest that knowledge, is to fall victim to the insidious effect of a hindsight                      
                 syndrome wherein that which only the inventor taught is used against its                              
                 teacher.”                                                                                             





















Page:  Previous  1  2  3  4  5  Next 

Last modified: November 3, 2007